NCT00999973Unknown1 期
Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 试验地点
- 1
研究概览
简要总结
In this study 126 eyes in 63 patients with moderate bilateral myopia and astigmatism between -3 and -5 (SE difference between two eyes should not be more than 0.75 and the residual corneal thickness>350 μ ) were entered in the study. One eye went randomly under PRK with mitomycin C 0.02% in 15 min and then the other eye went under the operation without MMC. UCVA,BCVA, refractory error after the operation and the number of endothelial cells before and after the surgery would be compared in 6 months.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •19 < age < 60
- •Refractory error stabled for at least one year
- •No corneal pathology
- •-3 < bilateral myopia and astigmatism < -5 with no difference more than 0.75 between 2 eyes
- •Exclusion criteria:
- •Keratoconus
- •Ectatic corneal disease
- •Corneal dystrophy
- •Lens changes affecting the visual acuity
- •Anterior or posterior uveitis
- •Corneal scar
排除标准
- 未提供
研究组 & 干预措施
Mitomycin c 0.02%
Active Comparator
干预措施: Mitomycin C 0.02% (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
3 期
Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle GlaucomaGlaucoma, Open-AngleNCT05710198Omikron Italia S.r.l.1,000
已完成
4 期
Effect of mitomycin C on higher order aberrations in low and moderate myopic (astigmatic) PRKMyopia.myopiaIRCT201008094537N1Tehran University of Medical science, Farabi Eye Research Center128
已完成
2 期
Ahmed Glaucoma Valve Surgery With Mitomycin-CNeovascular GlaucomaGlaucomaPrimary Open Angle GlaucomaSecondary GlaucomaNCT02805257University of California, San Francisco119
Unknown
不适用
Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin CRecurrent PterygiumNCT04463901Sun Yat-sen University116
招募中
2 期
A study to see how two different agents, Mitomycin C (commonly used) and bevacizumab (newer agent)influence the outcome of surgery for medically uncontrolled glaucoma.CTRI/2011/06/001836one60
